RE: A.I. "could the grail galleri test be improved using ctc's?" Yes.20 Jul 2025 17:49
Carrot
You continue to conflate early detection of cancer with circulating DNA fragments, usually pre-symptomatic, and the entirely different value of CTCs in determining therapeutic options for established malignacy with, in most cases, already established metastatic spread. The two processes look at different ends of the malignant process, and this is the likely reason why, despite your endless pleading and protestations on this board, AGL has not been taken up by the likes of Illumina or GRAIL.
Try to think of the use of cDNA as a screening test, where there is nothing by way of symptoms or signs to suggest malignancy, and CTCs as a means of determining therapeutic options in established disease.
Please accept that they are quite distinct.
Please stop confusing other members of this board.
As to the question of a T/O, not one of us has a clue.